title: Should cyclosporine be continued indefinitely?
authors.affiliation: Multi-Organ Transplant Service, University Hospital, Robarts Research Institute, University of Western Ontario London, Canada.
authors.forename: C R
authors.initials: CR
authors.lastname: Stiller
authors.forename: G
authors.initials: G
authors.lastname: Opelz
mesh_terms: D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D016206:Databases, Bibliographic; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology; D012307:Risk Factors
chemical_list: D003524:Cyclosporins